Insider Buying: Prospect Capital Co. (NASDAQ:PSEC) Insider Acquires 269,197 Shares of Stock (RegistrarJournal.com)
Prospect Capital Co. (NASDAQ:PSEC) insider John F. Barry purchased 269,197 shares of Prospect Capital stock in a transaction dated Wednesday, February 28th. The shares were bought at an average cost of $6.63 per share, for a total transaction of $1,784,776.11. The purchase was disclosed in a legal filing with the SEC.
Insider Selling: CytomX Therapeutics Inc (CTMX) CFO Sells 33,000 Shares of Stock (LedgerGazette.com)
CytomX Therapeutics Inc (NASDAQ:CTMX) CFO Debanjan Ray sold 33,000 shares of the business’s stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $29.99, for a total transaction of $989,670.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Insider Selling: Ichor Holdings Ltd (ICHR) Insider Sells 35,650 Shares of Stock (LedgerGazette.com)
Ichor Holdings Ltd (NASDAQ:ICHR) insider Philip Ryan Sr. Barros sold 35,650 shares of Ichor stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $25.47, for a total transaction of $908,005.50. The sale was disclosed in a document filed with the SEC.
Insider Selling: First Foundation Inc (FFWM) Director Sells 24,695 Shares of Stock (StockNewsTimes.com)
First Foundation Inc (NASDAQ:FFWM) Director Max Briggs sold 24,695 shares of the business’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $19.00, for a total transaction of $469,205.00. Following the completion of the transaction, the director now directly owns 11,101 shares of the company’s stock, valued at $210,919. The sale was disclosed in a legal filing with the Securities & Exchange Commission.
Insider Buying: Energen Co. (EGN) Director Buys 17,500 Shares of Stock (StockNewsTimes.com)
Energen Co. (NYSE:EGN) Director Jonathan Z. Cohen acquired 17,500 shares of the firm’s stock in a transaction that occurred on Friday, March 9th. The stock was bought at an average price of $57.36 per share, for a total transaction of $1,003,800.00. Following the completion of the transaction, the director now owns 17,500 shares of the company’s stock, valued at approximately $1,003,800. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Insider Buying: La Jolla Pharmaceutical (NASDAQ:LJPC) Director Buys 10,000 Shares of Stock (RegistrarJournal.com)
La Jolla Pharmaceutical (NASDAQ:LJPC) Director Kevin C. Tang acquired 10,000 shares of the company’s stock in a transaction dated Friday, March 2nd. The shares were bought at an average cost of $30.44 per share, for a total transaction of $304,400.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission.
